Paralemmin Antikörper (N-Term)
Kurzübersicht für Paralemmin Antikörper (N-Term) (ABIN928838)
Target
Alle Paralemmin (PALM) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Aufreinigung
- Purified
-
Immunogen
- PALM antibody was raised in rabbit using the N terminal of PALM as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
PALM Blocking Peptide, (ABIN940270), is also available for use as a blocking control in assays to test for specificity of this PALM antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Paralemmin (PALM)
-
Andere Bezeichnung
- PALM
-
Hintergrund
- This gene encodes a member of the paralemmin protein family. The product of this gene is a prenylated and palmitoylated phosphoprotein that associates with the cytoplasmic face of plasma membranes and is implicated in plasma membrane dynamics in neurons and other cell types. Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined. Synonyms: Polyclonal PALM antibody, Anti-PALM antibody, paralemmin antibody, KIAA0270 antibody.
-
Pathways
- cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Target
-